Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 167

1.

Variability in the expression of urokinase receptor (CD87) mutants on cells: relevance to cell adhesion.

Kanse SM, Chavakis T, Kuo A, Bdeir K, Cines DB, Preissner KT.

Cell Biochem Funct. 2004 Jul-Aug;22(4):257-64.

PMID:
15248186
2.

The uPA receptor and the somatomedin B region of vitronectin direct the localization of uPA to focal adhesions in microvessel endothelial cells.

Salasznyk RM, Zappala M, Zheng M, Yu L, Wilkins-Port C, McKeown-Longo PJ.

Matrix Biol. 2007 Jun;26(5):359-70.

PMID:
17344041
4.

Kinetic analysis of the interaction between vitronectin and the urokinase receptor.

Okumura Y, Kamikubo Y, Curriden SA, Wang J, Kiwada T, Futaki S, Kitagawa K, Loskutoff DJ.

J Biol Chem. 2002 Mar 15;277(11):9395-404.

PMID:
11773078
5.

Discrimination of different forms of the murine urokinase plasminogen activator receptor on the cell surface using monoclonal antibodies.

Rasch MG, Pass J, Illemann M, Høyer-Hansen G, Lund IK.

J Immunol Methods. 2008 Nov 30;339(1):55-65. doi: 10.1016/j.jim.2008.08.002.

PMID:
18761343
6.

A composite role of vitronectin and urokinase in the modulation of cell morphology upon expression of the urokinase receptor.

Hillig T, Engelholm LH, Ingvarsen S, Madsen DH, Gårdsvoll H, Larsen JK, Ploug M, Danø K, Kjøller L, Behrendt N.

J Biol Chem. 2008 May 30;283(22):15217-23. doi: 10.1074/jbc.C700214200.

PMID:
18362146
7.

Ligand binding regions in the receptor for urokinase-type plasminogen activator.

Liang OD, Chavakis T, Kanse SM, Preissner KT.

J Biol Chem. 2001 Aug 3;276(31):28946-53.

PMID:
11501527
8.

Molecular mechanisms of zinc-dependent leukocyte adhesion involving the urokinase receptor and beta2-integrins.

Chavakis T, May AE, Preissner KT, Kanse SM.

Blood. 1999 May 1;93(9):2976-83.

PMID:
10216093
9.

Urokinase-dependent human vascular smooth muscle cell adhesion requires selective vitronectin phosphorylation by ectoprotein kinase CK2.

Stepanova V, Jerke U, Sagach V, Lindschau C, Dietz R, Haller H, Dumler I.

J Biol Chem. 2002 Mar 22;277(12):10265-72.

PMID:
11756447
10.

Reciprocal regulation of urokinase receptor (CD87)-mediated cell adhesion by plasminogen activator inhibitor-1 and protease nexin-1.

Kanse SM, Chavakis T, Al-Fakhri N, Hersemeyer K, Monard D, Preissner KT.

J Cell Sci. 2004 Jan 26;117(Pt 3):477-85.

PMID:
14679304
11.

The urokinase receptor is a major vitronectin-binding protein on endothelial cells.

Kanse SM, Kost C, Wilhelm OG, Andreasen PA, Preissner KT.

Exp Cell Res. 1996 May 1;224(2):344-53.

PMID:
8612711
12.

The receptor for urokinase-type plasminogen activator regulates fibronectin matrix assembly in human skin fibroblasts.

Monaghan E, Gueorguiev V, Wilkins-Port C, McKeown-Longo PJ.

J Biol Chem. 2004 Jan 9;279(2):1400-7.

PMID:
14602715
13.

Mac-1 (CD11b/CD18) and the urokinase receptor (CD87) form a functional unit on monocytic cells.

Simon DI, Rao NK, Xu H, Wei Y, Majdic O, Ronne E, Kobzik L, Chapman HA.

Blood. 1996 Oct 15;88(8):3185-94.

PMID:
8874219
14.

Different mechanisms define the antiadhesive function of high molecular weight kininogen in integrin- and urokinase receptor-dependent interactions.

Chavakis T, Kanse SM, Lupu F, Hammes HP, Müller-Esterl W, Pixley RA, Colman RW, Preissner KT.

Blood. 2000 Jul 15;96(2):514-22.

PMID:
10887113
15.

Identification of the urokinase receptor as an adhesion receptor for vitronectin.

Wei Y, Waltz DA, Rao N, Drummond RJ, Rosenberg S, Chapman HA.

J Biol Chem. 1994 Dec 23;269(51):32380-8.

PMID:
7528215
17.

Domain 2 of the urokinase receptor contains an integrin-interacting epitope with intrinsic signaling activity: generation of a new integrin inhibitor.

Degryse B, Resnati M, Czekay RP, Loskutoff DJ, Blasi F.

J Biol Chem. 2005 Jul 1;280(26):24792-803.

PMID:
15863511
18.

Domain 1 of the urokinase receptor (uPAR) is required for uPAR-mediated cell binding to vitronectin.

Sidenius N, Blasi F.

FEBS Lett. 2000 Mar 17;470(1):40-6.

PMID:
10722842
19.

Function of the lectin domain of Mac-1/complement receptor type 3 (CD11b/CD18) in regulating neutrophil adhesion.

Xia Y, Borland G, Huang J, Mizukami IF, Petty HR, Todd RF 3rd, Ross GD.

J Immunol. 2002 Dec 1;169(11):6417-26.

PMID:
12444150
20.

Mannose 6-phosphate/insulin-like growth factor 2 receptor limits cell invasion by controlling alphaVbeta3 integrin expression and proteolytic processing of urokinase-type plasminogen activator receptor.

Schiller HB, Szekeres A, Binder BR, Stockinger H, Leksa V.

Mol Biol Cell. 2009 Feb;20(3):745-56. doi: 10.1091/mbc.E08-06-0569.

PMID:
19037107
Items per page

Supplemental Content

Support Center